Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Revenue (2016 - 2026)

Cumberland Pharmaceuticals' Revenue history spans 16 years, with the latest figure at $13.7 million for Q4 2025.

  • On a quarterly basis, Revenue rose 31.08% to $13.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $44.5 million, a 17.57% increase, with the full-year FY2025 number at $44.5 million, up 17.57% from a year prior.
  • Revenue hit $13.7 million in Q4 2025 for Cumberland Pharmaceuticals, up from $8.3 million in the prior quarter.
  • Over the last five years, Revenue for CPIX hit a ceiling of $13.7 million in Q4 2025 and a floor of $8.1 million in Q3 2021.
  • Historically, Revenue has averaged $10.0 million across 5 years, with a median of $10.0 million in 2023.
  • Biggest five-year swings in Revenue: decreased 18.92% in 2021 and later soared 41.38% in 2022.
  • Tracing CPIX's Revenue over 5 years: stood at $8.3 million in 2021, then grew by 9.66% to $9.1 million in 2022, then grew by 2.51% to $9.4 million in 2023, then increased by 11.57% to $10.4 million in 2024, then surged by 31.08% to $13.7 million in 2025.
  • Business Quant data shows Revenue for CPIX at $13.7 million in Q4 2025, $8.3 million in Q3 2025, and $10.8 million in Q2 2025.